Specialty Vision is an online directory, not a healthcare provider. Listed practices are not owned or operated by us.

Specialty Vision is an online directory and does not provide healthcare services. Listed practices and doctors are not owned, operated, or employed by Specialty Vision.

Laser Photocoagulation for Retinal Conditions

Understanding Laser Photocoagulation

Understanding Laser Photocoagulation

Laser photocoagulation is a procedure that uses a precisely focused beam of light to create tiny, controlled burns on the retina, the light-sensitive tissue lining the back of the eye. The term combines 'photo,' meaning light, and 'coagulation,' meaning to seal or clot. When the laser energy is absorbed by retinal tissue, it raises the temperature in a very small area. This heat causes proteins in the cells to change structure, forming small spots of scar tissue.

These spots of scar tissue serve specific purposes depending on the condition being treated. They can weld a torn retina back into place, seal leaking blood vessels, or reduce the oxygen demand of damaged retinal tissue. Laser photocoagulation was the first medical application of laser technology and remains a foundational tool in the prevention of blindness from retinal disease.

The laser works by delivering a brief pulse of light that the retinal tissue absorbs. This absorption converts light energy into heat energy at a precise, targeted location. The controlled heating causes the proteins in retinal cells to denature, meaning they change shape permanently. The body responds by forming scar tissue in these tiny spots.

Depending on the condition, a retina specialist may apply anywhere from a few dozen to several hundred laser spots in a single session. Each spot is carefully placed to achieve the desired result, whether that is sealing a tear, closing off a leaking vessel, or reducing the growth signals that drive abnormal blood vessel formation.

Retina specialists use laser photocoagulation to treat several conditions. The most common applications include the following:

  • Retinal tears: Sealing the edges of a tear to prevent it from progressing to a retinal detachment
  • Proliferative diabetic retinopathy (PDR): Slowing or stopping the growth of abnormal new blood vessels on the retina
  • Diabetic macular edema (DME): Sealing leaking blood vessels near the macula, the central area of the retina responsible for sharp vision
  • Retinal vein occlusion (RVO): Treating complications from blocked veins in the retina, including swelling and abnormal vessel growth
  • Lattice degeneration: Strengthening thin areas of the retina that may be at risk of developing tears

Types of Laser Photocoagulation

Focal laser treatment targets specific, small areas of the retina. A retina specialist uses this approach to seal individual leaking blood vessels or treat small clusters of abnormal vessels. This type is commonly used for diabetic macular edema, where specific blood vessels are leaking fluid into the macula and causing swelling that blurs central vision.

Because focal treatment involves only a limited number of laser spots in a precise area, it typically causes fewer side effects than broader treatments. The goal is to stop the leakage at its source while preserving as much surrounding healthy retinal tissue as possible.

Pan-retinal photocoagulation, also called scatter laser treatment or PRP, covers a much wider area of the retina. During PRP, a retina specialist applies hundreds of laser burns across the peripheral retina, deliberately avoiding the macula. This treatment is the standard intervention for proliferative diabetic retinopathy.

PRP works by reducing the overall oxygen demand of the peripheral retina. When parts of the retina are damaged by diabetes and not receiving enough blood supply, they release chemical signals that trigger the growth of fragile new blood vessels. By treating these oxygen-starved areas, PRP reduces the signals that drive abnormal vessel growth. Research has shown that PRP reduces the risk of severe vision loss from proliferative diabetic retinopathy by 50% (National Center for Biotechnology Information, 2015).

When a retinal tear is detected, a retina specialist can use laser photocoagulation to create a ring of scar tissue around the tear. This scar tissue acts like a spot-weld, bonding the retina firmly to the underlying tissue and preventing fluid from seeping through the tear and causing a retinal detachment.

This application is one of the most common and most successful uses of retinal laser. In a study of 430 eyes treated with laser photocoagulation for retinal tears, the success rate was 94% (Photocoagulation for Retinal Tears Study, 2006). Treating a tear early, before it progresses to a detachment, is far simpler and more effective than treating a full retinal detachment.

Who May Need Laser Photocoagulation

Diabetes is one of the leading reasons patients need laser photocoagulation. Diabetic retinopathy develops when high blood sugar damages the small blood vessels in the retina over time. Research from the Liverpool study found that 46% of people with type 1 diabetes had some form of diabetic retinopathy, with 4% having the proliferative form. Among people with type 2 diabetes, 25% had some diabetic retinopathy and 0.5% had proliferative disease (National Center for Biotechnology Information, 2015).

Patients with proliferative diabetic retinopathy or diabetic macular edema that does not respond fully to injection therapy may be recommended for laser treatment. In some cases, laser photocoagulation is used alongside anti-VEGF injections such as Eylea (aflibercept) or Avastin (bevacizumab), which is used off-label for eye conditions, to achieve better outcomes through combination therapy.

Retinal tears can happen to anyone but are more common in people who are nearsighted, have had previous eye surgery, have a family history of retinal detachment, or have experienced eye trauma. As people age, the vitreous gel inside the eye naturally shrinks and can pull on the retina, sometimes causing a tear.

Not every retinal tear requires treatment, but tears that are symptomatic, meaning they cause new floaters or flashes of light, carry a higher risk of progressing to retinal detachment. A retina specialist will evaluate the tear and recommend laser treatment when the risk of detachment is significant.

Retinal vein occlusion occurs when a vein carrying blood away from the retina becomes blocked. This can lead to swelling, bleeding, and the growth of abnormal new blood vessels. When these complications develop, laser photocoagulation may be used to reduce swelling or prevent further vessel growth. Treatment decisions depend on the type and severity of the occlusion and are often made in combination with anti-VEGF therapy.

What Happens During the Procedure

Laser photocoagulation is performed in the office of a retina specialist. Before the procedure begins, the specialist places numbing drops in the eye to minimize discomfort. The pupil is dilated with eye drops so the specialist can see the retina clearly. A special contact lens is then placed on the surface of the eye. This lens helps focus the laser beam precisely on the retina and keeps the eye steady during treatment.

The entire preparation typically takes about 15 to 30 minutes, most of which is waiting for the dilating drops to take full effect.

The patient sits at a slit lamp, a standard piece of equipment found in eye clinics. The retina specialist looks through the slit lamp and directs the laser through the contact lens onto the targeted areas of the retina. Each laser pulse lasts only a fraction of a second.

Most patients feel a mild stinging or pricking sensation with each pulse. Some spots may cause a brief, sharper discomfort, particularly during pan-retinal photocoagulation when many burns are applied. The treatment itself typically takes 10 to 30 minutes depending on the number of spots needed. For extensive PRP, the specialist may divide the treatment into two or more sessions spaced a few weeks apart to reduce discomfort and side effects.

Advances in laser technology have improved the patient experience. Pattern scanning laser photocoagulation, known as PASCAL, uses shorter pulse durations that require less total energy to create each burn. The shorter pulses produce smaller, more uniform burns with less spreading of heat into surrounding tissue. This results in less choroidal heating, less inner retinal injury, and reduced pain during treatment compared to conventional single-spot laser.

Targeted retinal photocoagulation, or TRP, is an emerging approach that uses imaging to identify specific areas of poor blood flow in the retina. The laser is then applied only to these ischemic areas rather than the entire peripheral retina. This targeted approach may reduce the total number of burns needed and lower the risk of side effects associated with traditional PRP.

Possible Side Effects and Risks

Some side effects are a normal part of the healing process after laser photocoagulation. Patients commonly experience the following:

  • Blurred vision for one to two days after treatment
  • Mild discomfort or a dull ache in or around the eye
  • Sensitivity to light for several hours after the procedure
  • Small blind spots in the areas where laser was applied, which may not be noticeable in daily life

Because PRP involves treating a large area of the retina, it can cause more noticeable changes in vision. Some patients experience a mild decrease in central vision, reduced night vision, decreased color perception, or reduced contrast sensitivity. Some loss of peripheral or side vision is also possible. These changes occur because the laser intentionally creates small areas of scar tissue across the peripheral retina.

While these side effects can be concerning, the vision changes from laser treatment are generally mild compared to the severe vision loss that untreated proliferative diabetic retinopathy can cause. The goal of PRP is to preserve the most important central vision by sacrificing small amounts of peripheral function.

Serious complications from laser photocoagulation are uncommon but can occur. These include bleeding inside the eye (vitreous hemorrhage), traction retinal detachment caused by contraction of scar tissue, and accidental laser burns to the fovea, the tiny central pit of the macula responsible for the sharpest vision. A foveal burn can result in significant central vision loss. Other rare complications include choroidal detachment and acute angle-closure glaucoma, a sudden increase in eye pressure.

A retina specialist takes careful precautions to minimize these risks, including precise targeting and appropriate energy settings. The risk of these complications is low, and for most patients, the benefits of preventing disease progression far outweigh the risks of treatment.

Recovery and What to Expect Afterward

Most patients can return to normal activities within a day or two after laser photocoagulation. Vision may be blurry for several hours to a couple of days. The eye may feel slightly sore or sensitive, but significant pain is uncommon. Over-the-counter pain relievers are usually sufficient for any discomfort.

Patients should avoid strenuous activity and heavy lifting for a few days, as directed by their retina specialist. Driving may not be safe on the day of treatment due to dilated pupils and blurred vision.

A retina specialist will schedule a follow-up visit, typically within two to six weeks after treatment, to check how the retina is healing. For retinal tears, the specialist will confirm that the scar tissue has formed a secure seal around the tear. For diabetic retinopathy, additional imaging and examination will determine whether the abnormal vessels have regressed or whether more treatment is needed.

Some patients require more than one laser session to achieve the desired result, particularly those undergoing PRP for proliferative diabetic retinopathy. The retina specialist will create an individualized follow-up plan based on the condition being treated and the response to the initial laser session.

Laser photocoagulation is frequently used alongside other treatments. For diabetic eye disease, a retina specialist may combine laser with anti-VEGF injections such as Eylea (aflibercept), Lucentis (ranibizumab), or Vabysmo (faricimab). Avastin (bevacizumab), which is FDA-approved for cancer but used off-label for eye conditions, is also commonly used. Research has shown that combining laser with these medications can produce better functional and structural outcomes than either approach alone in many patients.

For retinal tears, laser may be the only treatment needed if the tear is caught early. If a retinal detachment has already begun, surgery such as vitrectomy (removal of the gel inside the eye) or a scleral buckle (a silicone band placed around the eye) may be required in addition to or instead of laser.

When to See a Retina Specialist

Certain symptoms suggest a retinal tear or detachment may be developing and require urgent evaluation. See a retina specialist or go to the emergency room immediately if you experience any of the following:

  • A sudden increase in floaters, especially dark spots that look like someone shook pepper into your vision
  • Flashes of light, particularly in your peripheral vision
  • A shadow or curtain closing in from the side of your vision
  • Sudden blurred or lost vision in one eye

Retinal detachment can lead to permanent vision loss very quickly and should be treated as a medical emergency. Early treatment of a retinal tear with laser photocoagulation can often prevent a detachment from occurring.

If you have diabetes, retinal vein occlusion, or other conditions that affect retinal blood vessels, regular eye examinations with a retina specialist are essential. Many retinal conditions develop gradually without noticeable symptoms in their early stages. Routine dilated eye exams allow a specialist to detect changes early and recommend treatment before significant vision loss occurs.

Patients who have already undergone laser photocoagulation should continue with all recommended follow-up appointments. The conditions that require laser treatment are typically chronic and may need ongoing monitoring and additional treatment over time.

Questions and Answers

Most patients describe the sensation as a mild sting or prick with each laser pulse. Numbing drops are placed in the eye before the procedure to reduce discomfort. During pan-retinal photocoagulation, which involves many more laser spots, some patients feel a sharper sensation during certain pulses. Newer pattern scanning lasers such as PASCAL use shorter pulse durations and less energy, which has been shown to reduce pain during treatment. If discomfort is a concern, discuss options with your retina specialist beforehand.

The laser application itself typically takes 10 to 30 minutes. Including preparation time for numbing and dilating drops, the entire office visit usually lasts about one to two hours. For conditions requiring extensive treatment such as proliferative diabetic retinopathy, the retina specialist may split the treatment into two or more shorter sessions rather than completing all the laser spots at once.

Laser photocoagulation is primarily a preventive treatment. Its main purpose is to stop or slow the progression of retinal disease and preserve the vision you currently have. It does not typically restore vision that has already been lost due to retinal damage. In some cases, treating macular edema with laser can lead to modest improvement in vision as swelling decreases, but results vary from person to person.

The scar tissue created by laser is permanent, and a successfully sealed retinal tear generally stays sealed. However, new tears can form in other areas of the retina. For diabetic retinopathy, the underlying disease process continues as long as diabetes is present, and new abnormal vessels may develop over time. This is why ongoing monitoring and management of underlying conditions like blood sugar and blood pressure remain important even after successful laser treatment.

For some conditions, yes. Anti-VEGF injections have become a primary treatment for diabetic macular edema and are increasingly used for proliferative diabetic retinopathy. Medications such as Eylea (aflibercept) and Vabysmo (faricimab) can reduce abnormal vessel growth and macular swelling. For retinal tears, cryopexy (a freezing treatment) is an alternative that achieves a similar sealing effect. Your retina specialist will recommend the approach or combination of treatments best suited to your specific condition and needs.